HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Friedegund Meier Selected Research

Encephalitis (Encephalitis, Rasmussen)

12/2022Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
11/2022Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Friedegund Meier Research Topics

Disease

105Melanoma (Melanoma, Malignant)
05/2024 - 04/2003
47Neoplasms (Cancer)
05/2024 - 10/2003
32Neoplasm Metastasis (Metastasis)
04/2024 - 04/2003
20Skin Neoplasms (Skin Cancer)
12/2023 - 01/2016
11Brain Neoplasms (Brain Tumor)
01/2023 - 01/2013
8Uveal melanoma
10/2023 - 11/2019
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024 - 01/2020
4Disease Progression
07/2023 - 04/2016
3Merkel Cell Carcinoma
01/2023 - 10/2017
2Infections
02/2023 - 01/2021
2Encephalitis (Encephalitis, Rasmussen)
12/2022 - 11/2022
2Glioma (Gliomas)
12/2022 - 11/2022
2Pancreatitis
01/2021 - 01/2018
2Pneumonia (Pneumonitis)
02/2019 - 10/2014
2Lymphatic Metastasis
02/2019 - 06/2011
1Body Weight (Weight, Body)
11/2023
1Hypophysitis
11/2023
1Cardiomyopathies (Cardiomyopathy)
11/2023
1Wounds and Injuries (Trauma)
02/2023
1Hypotension (Low Blood Pressure)
01/2023
1Fever (Fevers)
01/2023
1Cytokine Release Syndrome
01/2023
1Leukocytosis (Pleocytosis)
11/2022

Drug/Important Bio-Agent (IBA)

39Immune Checkpoint InhibitorsIBA
12/2023 - 01/2017
20Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2023 - 09/2005
14VemurafenibIBA
12/2023 - 11/2012
12IpilimumabIBA
10/2022 - 12/2015
11NivolumabIBA
10/2023 - 01/2016
10Biomarkers (Surrogate Marker)IBA
05/2024 - 11/2016
10L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2023 - 04/2003
10pembrolizumabIBA
05/2023 - 01/2016
10Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2003
9AntibodiesIBA
05/2023 - 01/2016
6Mitogen-Activated Protein KinasesIBA
12/2023 - 02/2011
5CytokinesIBA
01/2023 - 05/2003
4cemiplimabIBA
03/2024 - 01/2020
4trametinibIBA
12/2023 - 10/2018
4Programmed Cell Death 1 ReceptorIBA
12/2021 - 01/2017
4Antineoplastic Agents (Antineoplastics)IBA
12/2016 - 08/2006
3encorafenibIBA
12/2023 - 10/2022
3dabrafenibIBA
12/2023 - 12/2015
3AntigensIBA
12/2023 - 06/2003
3tebentafuspIBA
06/2023 - 01/2023
3Phosphotransferases (Kinase)IBA
01/2023 - 07/2011
3Proto-Oncogene Proteins B-rafIBA
03/2021 - 01/2013
3MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
03/2021 - 11/2013
3LigandsIBA
03/2015 - 07/2004
2binimetinibIBA
12/2023 - 11/2023
2cobimetinibIBA
12/2023 - 11/2023
2bempegaldesleukinIBA
10/2023 - 01/2020
2tremelimumabIBA
01/2023 - 01/2019
2CTLA-4 AntigenIBA
01/2023 - 03/2018
2B7-H1 AntigenIBA
01/2023 - 03/2018
2Leucine (L-Leucine)FDA Link
12/2022 - 11/2022
2Cadherins (E-Cadherin)IBA
11/2022 - 09/2005
2Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 12/2021
2NVP-BKM120IBA
01/2020 - 12/2016
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2019 - 04/2018
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2017 - 08/2006
2Temozolomide (Temodar)FDA LinkGeneric
01/2017 - 06/2009
2Conditioned Culture MediaIBA
12/2016 - 02/2013
2Tumor Biomarkers (Tumor Markers)IBA
10/2013 - 04/2003
2Cisplatin (Platino)FDA LinkGeneric
06/2009 - 05/2007
2Integrin alphaVbeta3IBA
08/2006 - 09/2005
1Peptide Hydrolases (Proteases)FDA Link
05/2024
1Cytokine Receptors (Cytokine Receptor)IBA
04/2024
1Infliximab (Remicade)FDA Link
03/2024
1SteroidsIBA
03/2024
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2024
1Immunoglobulins (Immunoglobulin)IBA
03/2024
1RNA (Ribonucleic Acid)IBA
12/2023
1tributyl phosphate (TBP)IBA
11/2023
1PotassiumIBA
11/2023
1MicroRNAs (MicroRNA)IBA
10/2023
1Hematoxylin (Haematoxylon)IBA
07/2023
1Eosine Yellowish-(YS) (Eosin)IBA
07/2023
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2023
1HLA-A Antigens (HLA-A)IBA
01/2023
1cyclopropapyrroloindoleIBA
01/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2023
1durvalumabIBA
01/2023
1Monomeric GTP-Binding ProteinsIBA
01/2023
1EpitopesIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1MART-1 AntigenIBA
12/2021
1Interferon-gamma (Interferon, gamma)IBA
12/2021
1Peptide LibraryIBA
12/2021
1SDMIBA
04/2021
1C-PeptideIBA
01/2021

Therapy/Procedure

72Therapeutics
05/2024 - 06/2003
15Immunotherapy
10/2023 - 01/2013
10Radiotherapy
10/2022 - 05/2013
4Drug Therapy (Chemotherapy)
10/2017 - 05/2009
2Surgical Amputation (Amputations)
11/2023 - 02/2023
2Aftercare (After-Treatment)
06/2021 - 05/2009
2Lymph Node Excision (Lymph Node Dissection)
08/2013 - 01/2010
1Palliative Care (Palliative Therapy)
07/2023
1Terminal Care (Care, Terminal)
07/2023
1Neoadjuvant Therapy
10/2022
1Withholding Treatment
05/2021